Launch One Acquisition registered to offer 20 units at $10 each to target healthcare companies. A unit consists of one Class A share and one-half of a warrant, with whole warrants exercisable for a share at $11.50.
The underwriters have a 45-day option to purchase up to 3 million units to cover any over allotments. The sponsor has committed to buying 6 million warrants at $1 each.
The new SPAC plans to to identify and acquire a business focusing on the healthcare or healthcare-related industries and, in particular, life sciences, globally.
Chairman Ryan Gilbert is the general partner of Launchpad Capital, a financial services focused venture capital firm that he founded in 2020, and a senior advisor to Castle Creek Capital.
CEO Chris Ehrlich is the vice-chairman of CERo Therapeutics Holdings, which merged with Phoenix Biotech Acquisition in February.
Launch One intends to apply for a listing on the Nasdaq under the symbol LPAAU.
Cantor is sole book-running manager on this deal. Read more.
